|
|
|
Insider
Information: |
Zago Wagner M. |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Prothena Corp Plc |
PRTA |
|
2023-08-02 |
0 |
2017-09-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2017-09-28 |
4 |
AS |
$70.00 |
$63,000 |
D/D |
(900) |
0 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2017-09-28 |
4 |
OE |
$6.41 |
$5,769 |
D/D |
900 |
900 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2021-02-12 |
4 |
AS |
$17.07 |
$504,057 |
D/D |
(26,310) |
0 |
0 |
% |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2021-02-12 |
4 |
OE |
$6.41 |
$302,147 |
D/D |
26,310 |
18,750 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2021-02-18 |
4 |
AS |
$25.50 |
$192,270 |
D/D |
(7,540) |
0 |
0 |
% |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2021-02-18 |
4 |
OE |
$6.41 |
$48,331 |
D/D |
7,540 |
7,540 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2021-06-22 |
4 |
OE |
$15.04 |
$2,052,940 |
D/D |
115,250 |
115,250 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2021-06-22 |
4 |
AS |
$45.42 |
$5,318,769 |
D/D |
(115,250) |
0 |
0 |
% |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2023-06-07 |
4 |
AS |
$70.02 |
$1,350,224 |
D/D |
(19,000) |
0 |
0 |
% |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2023-06-07 |
4 |
OE |
$12.15 |
$495,750 |
D/D |
19,000 |
19,000 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2023-07-05 |
4 |
AS |
$67.98 |
$272,648 |
D/D |
(4,000) |
0 |
0 |
% |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2023-07-05 |
4 |
OE |
$12.15 |
$48,600 |
D/D |
4,000 |
4,000 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2023-08-02 |
4 |
OE |
$12.15 |
$48,600 |
D/D |
4,000 |
4,000 |
0 |
- |
|
PRTA |
Prothena Corp Plc |
Chief Scientific Officer |
|
2023-08-02 |
4 |
AS |
$66.98 |
$268,182 |
D/D |
(4,000) |
0 |
0 |
% |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|